145 related articles for article (PubMed ID: 17386969)
1. Effects of botulinum toxin A on the contractile function of dog prostate.
Lin AT; Yang AH; Chen KK
Eur Urol; 2007 Aug; 52(2):582-9. PubMed ID: 17386969
[TBL] [Abstract][Full Text] [Related]
2. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature.
Oeconomou A; Madersbacher H; Kiss G; Berger TJ; Melekos M; Rehder P
Eur Urol; 2008 Oct; 54(4):765-75. PubMed ID: 18571306
[TBL] [Abstract][Full Text] [Related]
3. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
4. Investigating botulinum toxin A on the functional properties of the prostate.
Choo MS
Eur Urol; 2007 Aug; 52(2):324-5. PubMed ID: 17376584
[No Abstract] [Full Text] [Related]
5. Intradetrusor botulinum neurotoxin A (BoNT-A) injections decrease bladder fibrosis secondary to partial urethral obstruction in the male rat model.
Tinay I; Tanidir Y; Cikler E; Cetinel S; Tarcan T
Neurourol Urodyn; 2012 Apr; 31(4):564-70. PubMed ID: 22275224
[TBL] [Abstract][Full Text] [Related]
6. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
Kuo HC
Urology; 2007 Jan; 69(1):57-61; discussion 61-2. PubMed ID: 17270614
[TBL] [Abstract][Full Text] [Related]
7. Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland.
Chuang YC; Huang CC; Kang HY; Chiang PH; Demiguel F; Yoshimura N; Chancellor MB
J Urol; 2006 Mar; 175(3 Pt 1):1158-63. PubMed ID: 16469644
[TBL] [Abstract][Full Text] [Related]
8. Lack of effectiveness of botulinum neurotoxin A on isolated detrusor strips and whole bladders from mice and guinea-pigs in vitro.
Howles S; Curry J; McKay I; Reynard J; Brading AF; Apostolidis A
BJU Int; 2009 Nov; 104(10):1524-9; discussion 1529-30. PubMed ID: 19466954
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.
Silva J; Pinto R; Carvallho T; Coelho A; Avelino A; Dinis P; Cruz F
Eur Urol; 2009 Jul; 56(1):134-40. PubMed ID: 18649990
[TBL] [Abstract][Full Text] [Related]
10. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
11. Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract.
Smith CP; Franks ME; McNeil BK; Ghosh R; de Groat WC; Chancellor MB; Somogyi GT
J Urol; 2003 May; 169(5):1896-900. PubMed ID: 12686869
[TBL] [Abstract][Full Text] [Related]
12. Prostatic involution after intraprostatic injection of cobra toxin.
Becker AM; Keck RW; Murtagh DS; Becker AB; Hinman C; Selman SH
J Urol; 2010 Nov; 184(5):2192-6. PubMed ID: 20850839
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin A for benign prostatic hyperplasia.
Oeconomou A; Madersbacher H
Curr Opin Urol; 2010 Jan; 20(1):28-36. PubMed ID: 19887944
[TBL] [Abstract][Full Text] [Related]
14. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A.
Chuang YC; Yoshimura N; Wu M; Huang CC; Chiang PH; Tyagi P; Chancellor MB
Eur Urol; 2007 Apr; 51(4):1119-27. PubMed ID: 17141941
[TBL] [Abstract][Full Text] [Related]
15. Effects of botulinum toxin A on functional outcome during distraction osteogenesis.
Olabisi R; Best TM; Vanderby R; Petr S; Noonan KJ
J Orthop Res; 2007 May; 25(5):656-64. PubMed ID: 17262822
[TBL] [Abstract][Full Text] [Related]
16. UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study.
Sycha T; Kotzailias N; Kranz G; Trautinger F; Schnider P; Auff E
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S92-6. PubMed ID: 17241421
[TBL] [Abstract][Full Text] [Related]
17. Perspective of Botox for treatment of male lower urinary tract symptoms.
Ilie CP; Chancellor MB
Curr Opin Urol; 2009 Jan; 19(1):20-5. PubMed ID: 19057212
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A for the treatment of delayed gastric emptying.
Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
[TBL] [Abstract][Full Text] [Related]
19. Effects of purified newly developed botulinum neurotoxin type A in rat prostate.
Nishiyama Y; Yokoyama T; Tomizawa K; Okamura K; Yamamoto Y; Matsui H; Oguma K; Nagai A; Kumon H
Urology; 2009 Aug; 74(2):436-9. PubMed ID: 19371936
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
